CDH2 and gastric cancer: In vitro studies have demonstrated that JPYZXZ inhibits the motility of gastric cancer cells, reduces tumor cell viability, and decreases the expression of EMT markers such as N-cadherin and Vimentin, while increasing E-cadherin expression149.